Erisipela Bolhosa: um relato de caso

Maria Eduarda Justino Ferreira; Renan Joseph  de Moraes Custódio

doi:10.51723/hrj.v4i19.508

Authors

Maria Eduarda Justino Ferreira
Renan Joseph de Moraes Custódio

DOI:

https://doi.org/10.51723/hrj.v4i19.508

Keywords:

Erysipelas, Skin Manifestations, Bacterial Infections, Case Reports

Abstract

Introduction: erysipelas is an acute bacterial infection of the dermis considered to be common. However, it can manifest in rarer forms, associated with complications, such as bullous erysipelas. Objective: to report the clinical presentation, management and evolution of a patient diagnosed with bullous erysipelas. Method: descriptive and observational study, a case report regarding a patient diagnosed with bullous erysipelas, hospitalized in a public hospital in Brasília, Federal District. Case Report: 46-year-old patient, obese, with history of chronic venous disease, presenting extensive involvement of the right lower limb by bullous erysipelas. Antibiotic therapy was used in association with topical treatment with silver foam dressings and silver sulfadiazine. Discussion: the patient in this case had several of the risk factors and presented possible entry portals for the infection, as well as most of the characteristic manifestations of the disease. Despite the gap in the literature related to the topical treatment, it was possible to observe a good evolution of the patient condition with the treatment strategy used. Conclusion: future researches could try to summarize the evidence related to erysipelas and its complications or apply the same treatment strategy in a larger number of patients to confirm its effectiveness.

References

Li A, Wang N, Ge L, et al. Risk factors of recurrent erysipelas in adult Chinese patients: a prospective cohort study. BMC Infect Dis 21, 26 (2021). Available from: https://doi.org/10.1186/s12879-020-05710-3

Sočan K, Sočan M. Trends in the epidemiology of erysipelas in Slovenia. Acta Dermatovenerol Alp Pannonica Adriat. 2018 Mar; 27 (1): 1-4. Available from: https://pubmed.ncbi.nlm.nih.gov/29589637/

Antar GM, Valéria P, Ferreira CMT. Feridas : prevenção, causas e tratamento. 1. ed. – Rio de Janeiro: Santos Ed., 2016.

Caetano M, Amorin I. Erisipela [Erysipelas]. Acta Med Port. 2005 Sep-Oct; 18 (5): 385-93. Disponível em: https://pubmed.ncbi.nlm.nih.gov/16611543/

Sunderkötter C, Becker K, Eckmann C, Graninger W, Kujath P, Schöfer H. Calculated initial parenteral treatment of bacterial infections: Skin and soft tissue infections. GMS Infect Dis. 2020 Mar 26; 8: Doc 11. Available from: https://pubmed.ncbi.nlm.nih.gov/32373436/

Krasagakis K, Samonis G, Maniatakis P, et al. Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance. Dermatology. 2006; 212 (1): 31–35. Available from: https://pubmed.ncbi.nlm.nih.gov/16319471/

Krasagakis K, Samonis G, Valachis A, Maniatakis P, Evangelou G, Tosca A. Local complications of erysipelas: a study of associated risk factors. Clin Exp Dermatol. 2011 Jun; 36 (4): 351-4. Available from: https://pubmed.ncbi.nlm.nih.gov/21198795/

Titou H, Ebongo C, Bouati E, Boui M. Risk factors associated with local complications of erysipelas: a retrospective study of 152 cases. Pan Afr Med J. 2017 Feb 5; 26: 66. Available from: https://pubmed.ncbi.nlm.nih.gov/28451043/

Edwards J, Green P, Haase D. A blistering disease: bullous erysipelas. CMAJ. 2006 Aug 1; 175 (3): 244. Available from: https://pubmed.ncbi.nlm.nih.gov/16880441/

Pasternack MS, Morton N. Swartz MN. 95 – Cellulitis, Necrotizing Fasciitis, and Subcutaneous Tissue Infections. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases (Eighth Edition). 2015. 1: 1194-1215. Available from: https://doi.org/10.1016/B978-1-4557-4801-3.00095-3

Licata G, De Rosa A, Gambardella A, Calabrese G, Argenziano G, Della Rocca MT, Alfano R. Bullous Erysipelas caused by Citrobacter koseri. J Clin Aesthet Dermatol. 2021 May; 14 (5): 12. Available from: https://pubmed.ncbi.nlm.nih.gov/34188743/

Saka B, Gnassingbe W, Akakpo S, Mahamadou G, Teclessou J, Mouhari-Toure A et al. Reasons for inpatient admissions to the dermatology department in Lomé, Togo: Trends between 1992 to 2005 and 2005 to 2016. Med Sante Trop. 2018 Aug 1; 28 (3): 270-272. Available from: https://pubmed.ncbi.nlm.nih.gov/30270828/

Brasil, Ministério da Saúde. Carta Circular nº 166/2018-CONEP/SECNS/MS – Esclarecimentos acerca da tramitação dos estudos do tipo “relato de caso” no Sistema CEP/Conep para a área biomédica. Brasília, DF. 2018. Disponível em: http://conselho.saude.gov.br/images/comissoes/conep/documentos/CARTAS/CartaCircular166.pdf

Brasil, Governo do Distrito Federal. Secretaria de Saúde do Distrito Federal. Diretoria de Enfermagem. Câmara Técnica de Cuidados com a Pele. Indicação dos curativos baseado nos produtos padronizados pela Secretaria de Saúde do Distrito Federal. 2019. 23 p.

Michael Y, Shaukat NM. Erysipelas. [Updated 2021 Aug 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532247/